{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:08:15Z","timestamp":1785128895223,"version":"3.55.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006314","name":"Biogen Italia","doi-asserted-by":"publisher","award":["2021"],"award-info":[{"award-number":["2021"]}],"id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegener. Dis. Manag."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2217\/nmt-2021-0038","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T14:20:23Z","timestamp":1650550823000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Healthcare Resource Utilization and Costs for Extended Interval Dosing of Natalizumab in Multiple Sclerosis"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-3090","authenticated-orcid":false,"given":"Marcello","family":"Moccia","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Clinical Care & Research Centre Department of Neuroscience Reproductive Science & Odontostomatology Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Loperto","sequence":"additional","affiliation":[{"name":"Department of Public Health Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Santoni","sequence":"additional","affiliation":[{"name":"Biogen Italy Via Giovanni Spadolini 5 20141\rMilan\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Masera","sequence":"additional","affiliation":[{"name":"Biogen Italy Via Giovanni Spadolini 5 20141\rMilan\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Affinito","sequence":"additional","affiliation":[{"name":"Department of Public Health Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care & Research Centre Department of Neuroscience Reproductive Science & Odontostomatology Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care & Research Centre Department of Neuroscience Reproductive Science & Odontostomatology Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Triassi","sequence":"additional","affiliation":[{"name":"Department of Public Health Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care & Research Centre Department of Neuroscience Reproductive Science & Odontostomatology Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Palladino","sequence":"additional","affiliation":[{"name":"Department of Public Health Federico II University Via Sergio Pansini 5 80131\rNaples\rItaly"},{"name":"Department of Primary Care & Public Health Imperial College\rReynolds Building\rSt Dunstan\u2019s Road\rW6 8RP\rLondon\rUK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"2","key":"e_1_3_5_3_1","first-page":"123","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"361","author":"Polman C","year":"2009","unstructured":"Polman C , O\u2019ConnorP, Havrdov\u00e1Eet al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med., 361(2), 123\u2013134 (2009).","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000672"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.03.017"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322326"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30282-X"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285614540224"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312940"},{"key":"e_1_3_5_10_1","first-page":"e1452","article-title":"Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing","volume":"93","author":"Zhovtis Ryerson L","year":"2019","unstructured":"Zhovtis Ryerson L , FoleyJ, ChangIet al. Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing. Neurology, 93, e1452\u2013e1462 (2019).","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_5_11_1","first-page":"P970","article-title":"Primary results of NOVA: a randomized controlled study of the efficacy of 6-week dosing of natalizumab versus continued 4-week treatment for multiple sclerosis","volume":"27","author":"Foley J","year":"2021","unstructured":"Foley J , DeferG, ZhovtisRyerson Let al. Primary results of NOVA: a randomized controlled study of the efficacy of 6-week dosing of natalizumab versus continued 4-week treatment for multiple sclerosis. Mult. Scler., 27(Suppl. 2), P970 (2021).","journal-title":"Mult. Scler."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17103388"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14040"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222012"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4207"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2722"},{"key":"e_1_3_5_18_1","unstructured":"Soggetto Aggregatore della Regione Campania . \u2018Anagrafica Farmaci\u2019 (2021). www.soresa.it\/pa\/Pagine\/Anagrafe.aspx"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03193146"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00776-7"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-015-0728-3"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517694432"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518820633"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122686"},{"issue":"4674","key":"e_1_3_5_25_1","first-page":"1","article-title":"Disease-modifying therapies for multiple sclerosis","volume":"363","author":"De Angelis F","year":"2018","unstructured":"De Angelis F , JohnN, BrownleeW. Disease-modifying therapies for multiple sclerosis. BMJ, 363(k4674), 1\u201310 (2018).","journal-title":"BMJ"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004686"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nmt-2021-0038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:48:22Z","timestamp":1716493702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nmt-2021-0038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2217\/nmt-2021-0038"],"URL":"https:\/\/doi.org\/10.2217\/nmt-2021-0038","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}